See every side of every news story
Published loading...Updated

Innovative product lighting the way for Horizon neurosurgeons, brain tumour patients - Horizon Health Network

Summary by horizonnb.ca
(HORIZON) – Horizon neurosurgeons are reporting significant positive results using a new, cutting-edge imaging agent to shed clearer light on malignant brain tumors – and the medical community is paying attention. Since 2020, Horizon neurosurgeons used an innovative diagnostic imaging liquid containing 5-aminolevulinic acid (5-ALA), Gleolan, in over 200 procedures at The Moncton Hospital (TMH) and the Saint John Regnal Hospital (SJRH). Patients …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

horizonnb.ca broke the news in on Monday, December 16, 2024.
Sources are mostly out of (0)